Anemia, a condition characterized by a decrease in the total number of red blood cells (RBCs) or hemoglobin, is a common clinical problem encountered by healthcare professionals. With a myriad of potential causes, anemia presents a diagnostic challenge requiring a systematic and comprehensive approach.
Anemia can be classified based on the morphological characteristics of RBCs or the pathophysiological processes involved. Microcytic, normocytic, and macrocytic anemias, each imply distinct etiologies, with iron deficiency, anemia of chronic disease, and vitamin B12 or folate deficiency, respectively. Pathophysiological classification includes production defects (hypoproliferative) and increased loss or destruction (hyperproliferative) of RBCs.
A thorough history and physical examination is the first step in the diagnostic workup. This should be followed by initial laboratory tests including complete blood count, reticulocyte count, and peripheral smear. Reticulocyte count helps distinguish between hypoproliferative and hyperproliferative anemias, while peripheral smear can provide clues on etiology. Further diagnostic tests should be guided by these initial results and clinical suspicion.
In situations where initial investigations are inconclusive, special tests may be necessary. These include serum iron studies, vitamin B12 and folate levels, hemoglobin electrophoresis, bone marrow examination, and tests for hemolysis. It is important to remember that these tests should be ordered judiciously, considering their cost and invasiveness.
While anemia is a common clinical problem, its causes are diverse and often complex. A systematic approach to diagnosis, beginning with a thorough history and physical examination, followed by appropriate laboratory tests, can help unravel the complexity of this condition. Special investigations should be reserved for cases where initial tests are inconclusive. This comprehensive diagnostic approach will enable healthcare professionals to accurately diagnose and effectively manage patients with anemia.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation